LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU=Cho Steven X.
  2. AU="Schlussel, Yvette"
  3. AU="Planellas, Pere"
  4. AU="Loh, Chiew Yee"
  5. AU="Shakir, Saad A W"
  6. AU="Ban, Hong-Xia"
  7. AU="Martinez, P. Concha"
  8. AU="Stoppa, Ian"
  9. AU="Lugo-Cob, R. G."
  10. AU="Natalie M Myres"
  11. AU="Andreas?Schumann"
  12. AU="S.Abraham, "
  13. AU="Panupinthu, Nattapon"
  14. AU="Bertl, Wilhelm"
  15. AU="Y M Dennis Lo"
  16. AU="Kesseli, Samuel J"
  17. AU=Patel Manisha
  18. AU="Jewitt, Debbie"
  19. AU=Karakose Oktay
  20. AU="Hu, Xiaolan"
  21. AU="Swamy, Samantha"
  22. AU="Kreykenbohm, I"

Suchergebnis

Treffer 1 - 10 von insgesamt 186

Suchoptionen

  1. Artikel ; Online: Thirteen years to get from b to a: one of the neglected isoforms of IL-37 enters the stage.

    Cho, Steven X / Rudloff, Ina / Ellisdon, Andrew M / Nold-Petry, Claudia A / Nold, Marcel F

    Cellular & molecular immunology

    2023  Band 21, Heft 2, Seite(n) 201–202

    Mesh-Begriff(e) Protein Isoforms ; RNA, Messenger
    Chemische Substanzen Protein Isoforms ; RNA, Messenger
    Sprache Englisch
    Erscheinungsdatum 2023-12-18
    Erscheinungsland China
    Dokumenttyp Letter ; Comment
    ZDB-ID 2435097-7
    ISSN 2042-0226 ; 1672-7681
    ISSN (online) 2042-0226
    ISSN 1672-7681
    DOI 10.1038/s41423-023-01111-z
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: The Role of the Interleukin-1 Family in Complications of Prematurity

    Elys A. Green / Steven P. Garrick / Briana Peterson / Philip J. Berger / Robert Galinsky / Rod W. Hunt / Steven X. Cho / Jane E. Bourke / Marcel F. Nold / Claudia A. Nold-Petry

    International Journal of Molecular Sciences, Vol 24, Iss 2795, p

    2023  Band 2795

    Abstract: Preterm birth is a major contributor to neonatal morbidity and mortality. Complications of prematurity such as bronchopulmonary dysplasia (BPD, affecting the lung), pulmonary hypertension associated with BPD (BPD-PH, heart), white matter injury (WMI, ... ...

    Abstract Preterm birth is a major contributor to neonatal morbidity and mortality. Complications of prematurity such as bronchopulmonary dysplasia (BPD, affecting the lung), pulmonary hypertension associated with BPD (BPD-PH, heart), white matter injury (WMI, brain), retinopathy of prematurity (ROP, eyes), necrotizing enterocolitis (NEC, gut) and sepsis are among the major causes of long-term morbidity in infants born prematurely. Though the origins are multifactorial, inflammation and in particular the imbalance of pro- and anti-inflammatory mediators is now recognized as a key driver of the pathophysiology underlying these illnesses. Here, we review the involvement of the interleukin (IL)-1 family in perinatal inflammation and its clinical implications, with a focus on the potential of these cytokines as therapeutic targets for the development of safe and effective treatments for early life inflammatory diseases.
    Schlagwörter prematurity ; inflammation ; bronchopulmonary dysplasia ; pulmonary hypertension ; white matter injury ; cerebral palsy ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Thema/Rubrik (Code) 610
    Sprache Englisch
    Erscheinungsdatum 2023-02-01T00:00:00Z
    Verlag MDPI AG
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: The Role of the Interleukin-1 Family in Complications of Prematurity.

    Green, Elys A / Garrick, Steven P / Peterson, Briana / Berger, Philip J / Galinsky, Robert / Hunt, Rod W / Cho, Steven X / Bourke, Jane E / Nold, Marcel F / Nold-Petry, Claudia A

    International journal of molecular sciences

    2023  Band 24, Heft 3

    Abstract: Preterm birth is a major contributor to neonatal morbidity and mortality. Complications of prematurity such as bronchopulmonary dysplasia (BPD, affecting the lung), pulmonary hypertension associated with BPD (BPD-PH, heart), white matter injury (WMI, ... ...

    Abstract Preterm birth is a major contributor to neonatal morbidity and mortality. Complications of prematurity such as bronchopulmonary dysplasia (BPD, affecting the lung), pulmonary hypertension associated with BPD (BPD-PH, heart), white matter injury (WMI, brain), retinopathy of prematurity (ROP, eyes), necrotizing enterocolitis (NEC, gut) and sepsis are among the major causes of long-term morbidity in infants born prematurely. Though the origins are multifactorial, inflammation and in particular the imbalance of pro- and anti-inflammatory mediators is now recognized as a key driver of the pathophysiology underlying these illnesses. Here, we review the involvement of the interleukin (IL)-1 family in perinatal inflammation and its clinical implications, with a focus on the potential of these cytokines as therapeutic targets for the development of safe and effective treatments for early life inflammatory diseases.
    Mesh-Begriff(e) Infant ; Pregnancy ; Female ; Infant, Newborn ; Humans ; Interleukin-1 ; Premature Birth ; Infant, Premature ; Anti-Inflammatory Agents/therapeutic use ; Bronchopulmonary Dysplasia/etiology ; Bronchopulmonary Dysplasia/drug therapy ; Infant, Newborn, Diseases/drug therapy ; Inflammation/complications ; Inflammation/drug therapy ; Retinopathy of Prematurity/drug therapy
    Chemische Substanzen Interleukin-1 ; Anti-Inflammatory Agents
    Sprache Englisch
    Erscheinungsdatum 2023-02-01
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24032795
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Challenges in determining death by neurologic criteria in extracorporeal membrane oxygenation - A single center experience.

    Zhao, David X / Caturegli, Giorgio / Wilcox, Christopher / Stephens, R Scott / Kim, Bo Soo / Keller, Steven / Geocadin, Romergryko G / Suarez, Jose I / Whitman, Glenn Jr / Cho, Sung-Min

    Perfusion

    2023  , Seite(n) 2676591231187548

    Abstract: Introduction: Apnea test (AT) in patients on extracorporeal membrane oxygenation (ECMO) support is challenging, leading to variation in determining death by neurologic criteria (DNC). We aim to describe the diagnostic criteria and barriers for DNC in ... ...

    Abstract Introduction: Apnea test (AT) in patients on extracorporeal membrane oxygenation (ECMO) support is challenging, leading to variation in determining death by neurologic criteria (DNC). We aim to describe the diagnostic criteria and barriers for DNC in adults on ECMO in a tertiary care center.
    Methods: A retrospective review of a prospective observational standardized neuromonitoring study was conducted in adult VA- and VV-ECMO patients at a tertiary center from June 2016 to March 2022. Brain death was defined according to the 2010
    Results: Eight (2.7%) ECMO patients (median age = 44 years, 75% male, 50% VA-ECMO) met criteria for DNC, six (75%) of whom were determined with AT. In the other two patients who did not undergo AT due to safety concerns, ancillary tests (transcranial doppler and electroencephalography) were consistent with DNC. An additional seven (2.3%) patients (median age = 55 years, 71% male, 86% VA-ECMO) were noted to have absent brainstem reflexes but failed to complete determination of DNC as they underwent withdrawal of life-sustaining treatment (WLST) before a full evaluation was completed. In these patients, AT was never performed, and ancillary tests were inconsistent with either neurological exam findings and/or neuroimaging supporting DNC, or with each other.
    Conclusion: AT was used safely and successfully in 6 of the 8 ECMO patients diagnosed with DNC and was always consistent with the neurological exam and imaging findings, as opposed to ancillary tests alone.
    Sprache Englisch
    Erscheinungsdatum 2023-06-30
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 645038-6
    ISSN 1477-111X ; 0267-6591
    ISSN (online) 1477-111X
    ISSN 0267-6591
    DOI 10.1177/02676591231187548
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: NLRC5/CITA expression correlates with efficient response to checkpoint blockade immunotherapy.

    Yoshihama, Sayuri / Cho, Steven X / Yeung, Jason / Pan, Xuedong / Lizee, Gregory / Konganti, Kranti / Johnson, Valen E / Kobayashi, Koichi S

    Scientific reports

    2021  Band 11, Heft 1, Seite(n) 3258

    Abstract: Checkpoint blockade-mediated immunotherapy is emerging as an effective treatment modality for multiple cancer types. However, cancer cells frequently evade the immune system, compromising the effectiveness of immunotherapy. It is crucial to develop ... ...

    Abstract Checkpoint blockade-mediated immunotherapy is emerging as an effective treatment modality for multiple cancer types. However, cancer cells frequently evade the immune system, compromising the effectiveness of immunotherapy. It is crucial to develop screening methods to identify the patients who would most benefit from these therapies because of the risk of the side effects and the high cost of treatment. Here we show that expression of the MHC class I transactivator (CITA), NLRC5, is important for efficient responses to anti-CTLA-4 and anti-PD1 checkpoint blockade therapies. Melanoma tumors derived from patients responding to immunotherapy exhibited significantly higher expression of NLRC5 and MHC class I-related genes compared to non-responding patients. In addition, multivariate analysis that included the number of tumor-associated non-synonymous mutations, predicted neo-antigen load and PD-L2 expression was capable of further stratifying responders and non-responders to anti-CTLA4 therapy. Moreover, expression or methylation of NLRC5 together with total somatic mutation number were significantly correlated with increased patient survival. These results suggest that NLRC5 tumor expression, alone or together with tumor mutation load constitutes a valuable predictive biomarker for both prognosis and response to anti-CTLA-4 and potentially anti-PD1 blockade immunotherapy in melanoma patients.
    Mesh-Begriff(e) Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy ; Intracellular Signaling Peptides and Proteins/genetics ; Melanoma/diagnosis ; Melanoma/drug therapy ; Melanoma/genetics ; Mutation/drug effects ; Prognosis
    Chemische Substanzen Immune Checkpoint Inhibitors ; Intracellular Signaling Peptides and Proteins ; NLRC5 protein, human
    Sprache Englisch
    Erscheinungsdatum 2021-02-05
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-82729-9
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: NLRC5/CITA expression correlates with efficient response to checkpoint blockade immunotherapy

    Sayuri Yoshihama / Steven X. Cho / Jason Yeung / Xuedong Pan / Gregory Lizee / Kranti Konganti / Valen E. Johnson / Koichi S. Kobayashi

    Scientific Reports, Vol 11, Iss 1, Pp 1-

    2021  Band 12

    Abstract: Abstract Checkpoint blockade-mediated immunotherapy is emerging as an effective treatment modality for multiple cancer types. However, cancer cells frequently evade the immune system, compromising the effectiveness of immunotherapy. It is crucial to ... ...

    Abstract Abstract Checkpoint blockade-mediated immunotherapy is emerging as an effective treatment modality for multiple cancer types. However, cancer cells frequently evade the immune system, compromising the effectiveness of immunotherapy. It is crucial to develop screening methods to identify the patients who would most benefit from these therapies because of the risk of the side effects and the high cost of treatment. Here we show that expression of the MHC class I transactivator (CITA), NLRC5, is important for efficient responses to anti-CTLA-4 and anti-PD1 checkpoint blockade therapies. Melanoma tumors derived from patients responding to immunotherapy exhibited significantly higher expression of NLRC5 and MHC class I-related genes compared to non-responding patients. In addition, multivariate analysis that included the number of tumor-associated non-synonymous mutations, predicted neo-antigen load and PD-L2 expression was capable of further stratifying responders and non-responders to anti-CTLA4 therapy. Moreover, expression or methylation of NLRC5 together with total somatic mutation number were significantly correlated with increased patient survival. These results suggest that NLRC5 tumor expression, alone or together with tumor mutation load constitutes a valuable predictive biomarker for both prognosis and response to anti-CTLA-4 and potentially anti-PD1 blockade immunotherapy in melanoma patients.
    Schlagwörter Medicine ; R ; Science ; Q
    Thema/Rubrik (Code) 616 ; 570
    Sprache Englisch
    Erscheinungsdatum 2021-02-01T00:00:00Z
    Verlag Nature Portfolio
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: MHC class I transactivator NLRC5 in host immunity, cancer and beyond.

    Cho, Steven X / Vijayan, Saptha / Yoo, Ji-Seung / Watanabe, Toshiyuki / Ouda, Ryota / An, Ning / Kobayashi, Koichi S

    Immunology

    2020  Band 162, Heft 3, Seite(n) 252–261

    Abstract: The presentation of antigenic peptides by major histocompatibility complex (MHC) class I and class II molecules is crucial for activation of the adaptive immune system. The nucleotide-binding domain and leucine-rich repeat receptor family members CIITA ... ...

    Abstract The presentation of antigenic peptides by major histocompatibility complex (MHC) class I and class II molecules is crucial for activation of the adaptive immune system. The nucleotide-binding domain and leucine-rich repeat receptor family members CIITA and NLRC5 function as the major transcriptional activators of MHC class II and class I gene expression, respectively. Since the identification of NLRC5 as the master regulator of MHC class I and class-I-related genes, there have been major advances in understanding the function of NLRC5 in infectious diseases and cancer. Here, we discuss the biological significance and mechanism of NLRC5-dependent MHC class I expression.
    Mesh-Begriff(e) Adaptive Immunity ; Animals ; Gene Expression Regulation ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/metabolism ; Humans ; Inflammasomes/genetics ; Inflammasomes/metabolism ; Intracellular Signaling Peptides and Proteins/genetics ; Intracellular Signaling Peptides and Proteins/metabolism ; Neoplasms/genetics ; Neoplasms/immunology ; Neoplasms/metabolism ; Signal Transduction ; Trans-Activators/metabolism ; Tumor Escape ; Tumor Microenvironment
    Chemische Substanzen Histocompatibility Antigens Class I ; Inflammasomes ; Intracellular Signaling Peptides and Proteins ; NLRC5 protein, human ; Trans-Activators
    Sprache Englisch
    Erscheinungsdatum 2020-08-03
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 80124-0
    ISSN 1365-2567 ; 0019-2805 ; 0953-4954
    ISSN (online) 1365-2567
    ISSN 0019-2805 ; 0953-4954
    DOI 10.1111/imm.13235
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis

    Ji-Seung Yoo / Michihito Sasaki / Steven X. Cho / Yusuke Kasuga / Baohui Zhu / Ryota Ouda / Yasuko Orba / Paul de Figueiredo / Hirofumi Sawa / Koichi S. Kobayashi

    Nature Communications, Vol 12, Iss 1, Pp 1-

    2021  Band 17

    Abstract: The presentation of viral antigens to T cells via the MHC molecules is a critical component of the host response to viral infection. Here the authors suggest SARS-CoV-2 possesses the immune evasion strategy against the MHC class I pathway by targeting ... ...

    Abstract The presentation of viral antigens to T cells via the MHC molecules is a critical component of the host response to viral infection. Here the authors suggest SARS-CoV-2 possesses the immune evasion strategy against the MHC class I pathway by targeting key transcriptional regulators.
    Schlagwörter Science ; Q
    Sprache Englisch
    Erscheinungsdatum 2021-11-01T00:00:00Z
    Verlag Nature Portfolio
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.

    Yoo, Ji-Seung / Sasaki, Michihito / Cho, Steven X / Kasuga, Yusuke / Zhu, Baohui / Ouda, Ryota / Orba, Yasuko / de Figueiredo, Paul / Sawa, Hirofumi / Kobayashi, Koichi S

    Nature communications

    2021  Band 12, Heft 1, Seite(n) 6602

    Abstract: The MHC class I-mediated antigen presentation pathway plays a critical role in antiviral immunity. Here we show that the MHC class I pathway is targeted by SARS-CoV-2. Analysis of the gene expression profile from COVID-19 patients as well as SARS-CoV-2 ... ...

    Abstract The MHC class I-mediated antigen presentation pathway plays a critical role in antiviral immunity. Here we show that the MHC class I pathway is targeted by SARS-CoV-2. Analysis of the gene expression profile from COVID-19 patients as well as SARS-CoV-2 infected epithelial cell lines reveals that the induction of the MHC class I pathway is inhibited by SARS-CoV-2 infection. We show that NLRC5, an MHC class I transactivator, is suppressed both transcriptionally and functionally by the SARS-CoV-2 ORF6 protein, providing a mechanistic link. SARS-CoV-2 ORF6 hampers type II interferon-mediated STAT1 signaling, resulting in diminished upregulation of NLRC5 and IRF1 gene expression. Moreover, SARS-CoV-2 ORF6 inhibits NLRC5 function via blocking karyopherin complex-dependent nuclear import of NLRC5. Collectively, our study uncovers an immune evasion mechanism of SARS-CoV-2 that targets the function of key MHC class I transcriptional regulators, STAT1-IRF1-NLRC5.
    Mesh-Begriff(e) COVID-19/genetics ; COVID-19/immunology ; COVID-19/pathology ; COVID-19/virology ; Cell Line ; Female ; Gene Expression Regulation ; Genes, MHC Class I/immunology ; Humans ; Interferon Regulatory Factor-1/antagonists & inhibitors ; Intracellular Signaling Peptides and Proteins/antagonists & inhibitors ; Male ; Middle Aged ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; STAT1 Transcription Factor/antagonists & inhibitors ; Signal Transduction ; Viral Proteins/immunology ; Viral Proteins/metabolism
    Chemische Substanzen IRF1 protein, human ; Interferon Regulatory Factor-1 ; Intracellular Signaling Peptides and Proteins ; NLRC5 protein, human ; ORF6 protein, SARS-CoV-2 ; STAT1 Transcription Factor ; STAT1 protein, human ; Viral Proteins
    Sprache Englisch
    Erscheinungsdatum 2021-11-15
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-021-26910-8
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Rab1A Is an mTORC1 Activator and a Colorectal Oncogene.

    Thomas, Janice D / Zhang, Yan-Jie / Wei, Yue-Hua / Cho, Jun-Hung / Morris, Laura E / Wang, Hui-Yun / Zheng, X F Steven

    Cancer cell

    2016  Band 30, Heft 1, Seite(n) 181–182

    Sprache Englisch
    Erscheinungsdatum 2016--11
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Published Erratum
    ZDB-ID 2078448-X
    ISSN 1878-3686 ; 1535-6108
    ISSN (online) 1878-3686
    ISSN 1535-6108
    DOI 10.1016/j.ccell.2016.06.014
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang